NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

This study (STRONG-DM) is testing whether a routine blood test called NT-proBNP — a marker that rises when the heart is under strain — can help primary care doctors screen their patients with type 2 diabetes for early signs of heart failure, and then intervene before the condition worsens. The study focuses on the doctors themselves as the participants, evaluating whether this screening tool changes clinical decision-making and improves how heart failure is prevented and detected in people with diabetes. **You may be eligible if...** - You are a primary care provider (doctor, nurse practitioner, or physician assistant) who sees patients with type 2 diabetes in your clinic - You are willing to use a decision support tool to guide screening and treatment conversations **You may NOT be eligible if...** - You do not see patients with type 2 diabetes in your clinical practice - You are not a primary care provider Talk to your study team to see if this trial is right for you.